PREVENTION OF CYCLOPHOSPHAMIDE CYSTITIS WITH 2-MERCAPTOETHANE SODIUM-SULFONATE - A HISTOLOGIC-STUDY

被引：30

作者：

FREEDMAN, A ^{[1
]}

EHRLICH, RM ^{[1
]}

LJUNG, BM ^{[1
]}

机构：

[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90024

来源：

关键词：

D O I：

10.1016/S0022-5347(17)49751-5

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：580 / 582

页数：3

共 10 条

[1] ANTIDOTE AGAINST THE UROTOXIC SIDE-EFFECTS OF THE OXAZAPHOSPHORINE DERIVATES CYCLOPHOSPHAMIDE, IFOSFAMIDE AND TROFOSFAMIDE
BROCK, N
STEKAR, J
POHL, J
[J]. NATURWISSENSCHAFTEN, 1979, 66 (01) : 60 - 61
[2] BROCK N, 1979, ARZNEIMITTEL-FORSCH, V29-1, P659
[3] CYCLOPHOSPHAMIDE CYSTITIS - IDENTIFICATION OF ACROLEIN AS THE CAUSATIVE AGENT
COX, PJ
[J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (13) : 2045 - 2049
[4] INCIDENCE OF BLADDER-CANCER AFTER CYCLOPHOSPHAMIDE THERAPY
FAIRCHILD, WV
SPENCE, CR
SOLOMON, HD
GANGAI, MP
[J]. JOURNAL OF UROLOGY, 1979, 122 (02) : 163 - 164
[5] FORNI AM, 1964, CANCER, V17, P1348, DOI 10.1002/1097-0142(196410)17:10<1348::AID-CNCR2820171017>3.0.CO
[6] 2-0
[7] KOSS LG, 1967, LAB INVEST, V16, P44
[8] PHILIPS FREDERICK S., 1961, CANCER RES, V21, P1577
[9] POHL J, 1982, TOXICOLOGY PHARMACOK
[10] WALKER SE, 1971, J LAB CLIN MED, V78, P978